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COVID-19 Outbreak Effects on Job
Security and Emotional Functioning
Amongst Women Living With Breast
Cancer
Bethany Chapman* , Jessica Swainston, Elizabeth A. Grunfeld and Nazanin Derakshan
Department of Psychological Sciences, Birkbeck, University of London, London, United Kingdom
The outbreak of Coronavirus disease 2019 (COVID-19) has negatively impacted global
economies and employment. In the UK, it is predicted that approximately eight million
jobs were furloughed as a result of the outbreak and the associated restriction of
movement or shielding measures. This study aimed to investigate the impact of changes
in employment status on cognitive and emotional health as well as perceptions of
work. Furthermore, it examined the relationships between women’s job security and
anxiety, depression and cognitive function. Women living with breast cancer (N = 234)
completed online questionnaires to measure their cognitive function, general emotional
well-being, COVID-19 related emotional vulnerability (COVID-EMV), work ability and
COVID-19 related perceptions of work. Our results revealed that threat to job security
was predictive of depression and cognitive function in the entire sample Such that those
with higher levels of perceived job security had lower depression and better cognitive
function. Further, women who were furloughed or unable to continue work reported
higher job insecurity compared to those who had worked throughout the pandemic.
Greater rumination was also associated with worse anxiety and depression as well as
poorer cognitive function. Finally, moderation analysis highlighted that women who had
better cognitive functioning were less likely to experience anxiety when their job security
was high. Given our findings, we suggest that employers provide women with accessible
interventions to enhance cognitive and emotional resilience and thus help protect
against the detrimental effects of job insecurity created by the COVID-19 outbreak.
Keywords: breast cancer, COVID-19, anxiety, depression, cognition, employment, job security
INTRODUCTION
Coronavirus disease 2019 (COVID-19) has had a substantial impact on global economies
and individual employment (Qualtrics, 2020). In the United Kingdom (UK), the government
announced a social lockdown to reduce the spread of the virus and prevent the National Health
Service (NHS) becoming overwhelmed by large numbers of COVID-19 cases (Government, UK,
2020). The lockdown included a ban on all non-essential travel as well as the closure of the majority
of non-essential businesses, instructing workforces to complete their work from home (if feasible).
Where working at home was not possible, companies either issued redundancies or furloughed
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staff under the government Job Retention Scheme. It is estimated
that over eight million jobs were furloughed in the UK, during
which time the Government paid up to 80% of the UK median
salary, to a maximum of £2,500 (Bell et al., 2020). Recent
figures, however, indicate that being furloughed by an employer is
associated with poorer mental health, with higher levels of stress
and anxiety recorded (Qualtrics, 2020).
The COVID-19 crisis has been a particularly concerning
time for vulnerable groups of individuals living with pre-
existing health conditions, including women with a breast cancer
diagnosis. Whilst the advances in medical treatment and earlier
diagnosis mean that a significant proportion of women now
survive a diagnosis for many years (10-year survival rate is
76%; Breast Cancer Now, 2020), the longer-term consequences
and sequela of breast cancer and its treatment(s) are now
well-established. Indeed, up to 75% of women report post-
treatment cancer-related-cognitive-impairments (CRCI) (Jansen
et al., 2011; Koppelmans et al., 2012; Ganz et al., 2013; Janelsins
et al., 2014; see Ahles and Root, 2018 for review) which are
associated with greater levels of anxiety and depression (Kaiser
et al., 2019; see Papanastasiou et al., 2019 for review). Similarly,
CRCI’s have been associated with a poorer quality of life
(Menning et al., 2016) and worse work ability (Calvio et al., 2010;
Zeng et al., 2016).
However, being in work is considered instrumental to
women’s cognitive and emotional recovery and in promoting a
better quality of life (Timperi et al., 2013; Keim-Malpass et al.,
2016). The beneficial effects of work on cognitive ability may
occur through increasing neuroplasticity (or cognitive reserve)
of the brain via consistent positive stimulation (i.e., processing
of new or complex information through social interaction within
the workplace), as well as by reduced levels of anxiety, depression
and the lessening of financial-related stress, as a consequence of
receiving a wage (Vance et al., 2016). Furthermore, being in work
has significant psychological benefits including providing a sense
of meaning, identity and normality for many women living with
cancer (Rasmussen and Elverdam, 2008; Johnsson et al., 2010;
Blinder et al., 2012).
Conversely, involuntary job loss and unemployment have
consistently been shown to have a significant and long-term
impact on mental health (Gallo et al., 2000). Compounding
this, the emergence of depression following job loss increases
the risk of continued unemployment (Stolove et al., 2017). In
the same way, job insecurity is considered to be a stressor that
is detrimental to well-being and mental health (Llosa et al.,
2018), and is associated with increased levels of depression
(Blom et al., 2015). Such adverse outcomes are of additional
concern for vulnerable populations already experiencing high
levels of emotional distress (anxiety and depression). Women
living with breast cancer have a greater risk for developing
clinical affective disorders, including long-term anxiety and/or
depression, as well as elevated levels of worry (Burgess et al.,
2005; Avis et al., 2015; Cvetković and Nenadović, 2016; see
Carreira et al., 2018 for a review). Studies have shown that both
worry and rumination are significantly associated with anxiety
and depression (Nolen-Hoeksema, 2000; Beckwé et al., 2014;
Ryum et al., 2017; Spinhoven et al., 2018; Brown et al., 2020).
Moreover, women living with breast cancer are at a greater risk
of experiencing suicidal ideations and suicide up to 25 years
after their diagnosis (Schairer et al., 2006; Gaitanidis et al., 2018;
see Carreira et al., 2018 for review) compared to the general
population. This is of significance as it is estimated that a rise
in unemployment in the general population from 4.94 to 5.64%
(24.7 million job losses, worldwide) as a result of COVID-19
could be accompanied by an additional 9,570 suicides each year
(Kawohl and Nordt, 2020).
In view of these existing predispositions and the value placed
on work by women after diagnosis and treatment, women
living with a breast cancer diagnosis are more susceptible to
experiencing emotional disorders and poorer mental health
outcomes as a result of the distress and trauma caused by
threats to job loss and job security. As such, we aimed to
examine the effects of COVID-19 generated employment status
(i.e., continued working or being furloughed) on perceptions
of job security, work importance and employer support in
response to the pandemic. We also aimed to investigate how
threats to job security would predict levels of emotional distress
including anxiety and depressive related symptomatology as
well as cognitive function. We predicted that there would be
differences in women’s perceptions of work depending on their
COVID-19 generated employment status. We also predicted
that the threat and uncertainty induced by COVID-19 to
employment security would be associated with worse cognitive




A cross-sectional survey design was utilized. The study was
approved by the Research Ethics Committee of the Department
of Psychological Sciences, the College Research Ethics Committee
at Birkbeck College, University of London, and the Economic and
Social Research Council.
Participants
Women were recruited using voluntary sampling via
advertisements on social media platforms such as “Building
Resilience in Breast Cancer Centre” (BRiC Centre)1 2 and Breast
Cancer Now3 during the peak of the COVID-19 outbreak in
the UK. Participants completed this study between the 9th of
April and 26th of May 2020. The inclusion criteria for this study
were women aged 18 years or older, living with a diagnosis of
breast cancer, at any stage of active treatment, hormone blocker
therapy or target therapy. Women could also be employed,
self-employed, undertaking voluntary work or not undertaking
any work at the time of recruitment.
1The Birkbeck Integrative Centre for Building Resilience in Breast Cancer (BRiC)
delivers interactive psycho-educational support for woman living with primary
or secondary breast cancer in the UK. To date, the BRiC centre has 1,827 UK
members with a diagnosis of breast cancer.
2http://briccentre.bbk.ac.uk/
3https://breastcancernow.org/
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Materials
Demographic and Clinical Questionnaire (DQ)
The self-reported DQ (developed by the authors) comprises of
29-items (i.e., grade or type of treatment), sociodemographic
factors (i.e., education, ethnicity and civil status), pre-existing
psychological or affective disorders and employment including
employment type (i.e., employed or self-employed), collar group,
employment sector and the number of hours worked (part-
time or full-time).
Functional Assessment of Cancer Therapy-Cognitive
Scale (FACT-Cog, Version 3; Wagner et al., 2009)
The 37-item Fact-Cog is widely used in breast cancer research
(Von Ah and Tallman, 2015; Von Ah et al., 2018) to assess
self-reported cognitive impairment (PCI measured by 20 items),
cognitive ability (PCA measured by nine item questions),
the impact of cognitive impairment on quality of life (QoL
measured by four items) and others’ comments about cognitive
impairments (CFO measured by four items). Items are measured
on a five-point Likert scale from “never” or “not at all” (0) to
“several times a day” or “very much” (4) with negatively phrased
items (PCI, QoL, CFO) reverse scored. The total score ranges
from 0 to 148, with a higher total score calculated from the
summation of the four subscales indicating a better cognitive
function. Current study’s Cronbach’s α = 0.97.
Rumination Response Scale (RRS; Treynor et al.,
2003)
The self-report RRS is a highly reliable questionnaire which
has been used previously in breast cancer research (Steiner
et al., 2014). The RRS assesses the severity of depressive
rumination experienced by an individual. All 22-item statements
are measured on a Likert scale with 1 indicating “never” and 4
“almost always.” The total score from the summation of items
ranges from 22 to 88, with greater scores showing a higher
rumination. Current study’s Cronbach’s α = 0.94.
Hospital Anxiety and Depression Scale (HADS;
Zigmond and Snaith, 1983)
The HADS examines the severity of anxiety and depression
symptomology experienced over the last week. In particular, the
HADS assesses 14 items on a Likert scale with response scores
ranging from 0 to 3. Seven item statements measure anxiety and
seven measure depression. Scores range from 0 to 21, with greater
scores on each of the subscales showing that a worse severity
of symptomology is being experienced. The HADS is widely
implemented in breast cancer research (Osborne et al., 2004; Akel
et al., 2017) and has been shown to adequately measure anxiety
and depression in breast cancer (Hopwood et al., 1991). Current
study’s Cronbach’s α = 0.89.
Penn State Worry Questionnaire (PSWQ; Meyer et al.,
1990)
The PSWQ is widely used including, in the breast cancer
population (Swainston and Derakshan, 2018) to assess the level of
trait worry being experienced by an individual. All 16 self-report
items are measured on a five-point Likert scale with 1 indicating
that the statement behavior is “not typical of me” and 5 “very
typical of me.” The total score ranges from 16 to 80, with a higher
total score indicating a worse level of pathological worry. Current
study’s Cronbach’s α = 0.94.
Modified Self-Report-Generated Charlson
Comorbidity (CCI; Charlson et al., 1987)
The modified CCI assesses health comorbidities (i.e., “heart
trouble” and “kidney disease”) experienced by an individual.
Each of the 9 comorbidities [(1) Asthma, emphysema or
chronic bronchitis, (2) Arthritis or rheumatism, (3) Diabetes, (4)
Digestive problems, (5) Heart trouble, (6) HIV illness or AIDS,
(7) Kidney disease, (8) Liver problems, (9) stroke] included in
the questionnaire is weighted (value of 1, 2, 3, or 6) with a more
severe comorbidity given a higher value (i.e., “HIV illness or
AIDS” has a weighted value of 6). Items are summed together to
form the overall score. Greater scores show worse comorbidity.
The CCI has previously been used in breast cancer research
(Fu et al., 2015).
Work Limitations Questionnaire (WLQ; Lerner et al.,
2001, 2003)
The WLQ is a self-report inventory composed of 25 positively
or negatively phrased items that measure how health-related
condition(s) such as breast cancer impact everyday workplace
performance and productivity (Von Ah et al., 2018). Items
are divided into four sub-domains (Time Management Scale,
Physical Demands Scale, Mental/Interpersonal Demands Scale
and the Output Demands Scale) and measured on a five-
point Likert scale from 1 [“difficult all of the time (100%)”
or “able all of the time (100%)”] to 5 [“difficult none of the
time (0%)” or “able none of the time (0%)”] with reverse
scoring for subscales 1, 3, and 4. The percentage of work
productivity loss in the workplace over the last 2 weeks is
calculated from the four subscale total scores. Each of the four
sub-domains has a scoring range from 0 to 100 after conversion,
with higher scores indicating a greater level of difficulty in the
workplace. Applying the exponential formula, a percentage score
for work productivity loss is calculated (the maximum attainable
score for work productivity loss is 24.9%), a higher score
represents a greater loss of work productivity. Current study’s
Cronbach’s α = 0.97.
COVID-19 Items
The COVID-19 items (developed by the authors) assess the
impact of the COVID-19 pandemic and lockdown on women
living with breast cancer. There are two subsections, the first
(comprising of 16 items) includes individual items exploring
the effects of the pandemic on women’s emotional vulnerability.
Specifically, these items ask participants to reflect on whether
the outbreak has made them feel more (1) anxious, (2) upset,
(3) fearful or less (4) in control, and (6) confident. A reliable
composite score from these five items was created (Cronbach’s
α = 0.89) and referred to as COVID-EMV. Items examining
the COVID-19 symptoms experienced during the pandemic (i.e.,
fever, cough, shortness of breath, chest pain or pressure, sore
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throat, sneezing or runny nose, loss of smell or taste), self-
isolation status, disruption to oncology appointments, receipt
of the UK Government shielding letter as well as the concerns
associated with the restrictive measures imposed by the shielding
letter were developed.
The second subsection comprised of eight individual items
that assess the impact of COVID-19 outbreak on women’s current
work status (i.e., working or not work due to COVID-19) and
asks participants to reflect on how COVID-19 has changed or
impacted their views of work (“has the COVID-19 outbreak
changed your view on the importance of your work?,” “how has
the COVID-19 outbreak impacted your job satisfaction?” “has the
COVID-19 outbreak changed how confident you feel at work?,”
“has the COVID-19 outbreak changed your view on how secure
your job is?”). Employer’s support in response to the pandemic
is also assessed (“please rate your employer’s support in response
to the COVID-19 impact on work”). All items are measured on
a Likert scale ranging from “much less” or “not at all” (0) to
“much more” or “extremely” (5), with higher scores indicate more
positive views of work and better employer support. Cronbach’s
α = 0.74. Individual work items were used in our analysis.
Procedure
Women who responded (by email) to one of the study
advertisements on social media platforms were sent a return
email containing the study information and a secure URL to
access the questionnaire. Participants were asked to provide
online consent before completing the battery of online
questionnaires. All participants were instructed to complete the
DQ, the general cognitive and emotional health questionnaires
and the main COVID-19 subsection. Participants who reported
that they were employed, self-employed or who undertook
volunteering work were asked to additionally complete the
COVID-19 work subsection and the WLQ. A £5 gift voucher was
emailed to all participants upon completion.
Statistical Analysis
Data analyses were conducted using the Statistical Package
for the Social Sciences (SPSS, version 25). Participant clinical,
sociodemographic and work characteristics were explored with
descriptive statistics (see Table 1).
One-way ANOVA’s were used to investigate the impact of
employment status (i.e., working, not working due to COVID-
19 or never working) on cognitive function, general anxiety and
depression as well as COVID-19 related emotional vulnerability
(COVID-EMV). Partial eta squared effect sizes were calculated.
In addition, two independent t-tests were performed to examine
the effects of employment type (employed vs. self-employed) on
women’s general levels of anxiety and depression during this
outbreak. Furthermore, independent t-tests were conducted to
explore the effects of COVID-19 generated work status (i.e.,
continued working or furloughed) on employer support, the
importance of work and job security. Cohen’s d effect sizes were
calculated. Post-hoc analyses were conducted using G∗Power
software (Faul et al., 2007, 2009).
Hierarchical regression analyses were run to examine
the relationship of women’s job security to four dependent
TABLE 1 | Clinical, sociodemographic, and work characteristics.
N = 234 (%)
Sociodemographic
Age Mean = 51 Years
(Min = 27, Max = 78)
Education
Secondary education 26 (11.1)
Further education 50 (21.4)















Undertaking volunteering work 14 (6.0)
Not undertaking any form of work 48 (20.5)
Collar groupc
White collar 117 (65.7)
Pink collar 51 (28.7)
Blue collar 3 (1.7)
Other 7 (3.9)
Clinical—Breast cancer history
Age at diagnosis Mean = 47 Years
(Min = 24, Max = 77)
Time since diagnosis Mean = 51.46 Months
(Min = 0, Max = 177)
Gradec
Grade 1 28 (12.0)
Grade 2 86 (36.8)




Due to start 2 (0.9)
Other 2 (0.9)










Other (i.e., Prescribed but decided not to take it) 10 (4.3)
Time since treatment finished Mean = 38 Months
(Min = 0, Max = 140)
History of psychological disorders 100 (42.7)
Prescribed medication for conditions other than cancer 49 (20.9)
aOne participant did not report their ethnicity. bFour participants did not state their
current civil status. cFifty-six participants (including those not undertaking any form
of work) did not report their collar group. dThree participants did not report their
breast cancer grade. eOne participant did not report the type of treatment received.
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variables including, cognitive function, anxiety and depression
as well as emotional distress after allowing for clinical and
sociodemographic predictors as well as employment type (i.e.,
employed, self-employed or volunteering). On the first step, (1)
education level, (2) age at diagnosis, (3) time since diagnosis
(in months), (4) treatment status, (5) grade of breast cancer,
(6) pre-existing co-morbidities (assessed by the CCI) and (7)
employment type were added. Women’s rumination, worry
and COVID-19-EMV were entered on step two. Finally, job
security was included in the third step. Cohen’s f 2 effect
sizes were calculated for each of the regressions. Assessing
standardized residuals, no outliers were identified in the four
regression analyses: anxiety (std Residual Min = −2.4, std
Residual Max = 2.6), depression (std Residual Min = −2.3, std
Residual Max = 2.9), emotional distress (std Residual Min = −2.2,
std Residual Max = 2.7) and cognitive function (std Residual
Min = −2.6, std Residual Max = 2.4). In addition, no violations
of the assumptions of collinearity, independent error, normality,
homoscedasticity and linearity were found. Post-hoc achieved
power calculations were carried out with G∗Power software (Faul
et al., 2007, 2009) using Cohen f 2 and a significance of 0.05.
Finally, moderation analyses were conducted to explore
the moderating role of cognitive function on job security
in predicting general anxiety and depression. Self-reported
cognitive function and job security were mean-centered prior
to analyses. Checks for violations of the assumption of
heteroscedasticity were performed and all standard errors in
the model were based on the Heteroscedasticity Consistent
Standard Error (HC1).
There was no missing questionnaire data for the FACT-
Cog, HADS, RRS, PSWQ, and CCI in the present study.
Scores for the four sub-scales of the WLQ (time management
demands, physical demands, mental/interpersonal demands and
work output demands) were calculated if half or more of the
scale’s questions had been answered by dividing the sum of the
answered questions by the number of answered questions and
then converted into a final scale score. Missing data in the WLQ
was likely due to the COVID-19 induced work changes. Only
13 participants who were employed but furloughed or unable to
work as a result of the COVID-19 outbreak failed to complete
the individual COVID-19 work items. These participants were
excluded from any analysis examining these items as scale
and person-specific means were unable to be computed and
substituted for the missing items.
RESULTS
Sample Description
Women recruited to participate in the current study (N = 234)
were between the age of 27 and 78 years old (Mean = 51 years;
see Table 1 for participant clinical, sociodemographic and work
information) and had a diagnosis of primary breast cancer. Of
the 234 women who participated, 35 (15%) stated that they
had experienced COVID-19 symptoms (4.7% high fever, 5.5%
cough) although no cases had been officially diagnosed, and no
hospital admissions were reported. Most of the women reported
TABLE 2 | Means and standard deviations for symptomology measured.
Employed Self-Employed
M SD M SD
Anxiety 9.4 4.7 9.5 4.1
Depression 6.7 4.0 6.9 4.2
Cognitive function 88.5 29.4 86.5 26.6
Rumination 47.6 14.4 44.2 14.6
Worry 52.1 14.6 51.2 17.1
Health anxiety 17.8 6.9 18.6 6.8
that they were either employed (147, 62.8%), self-employed (25,
10.7%) or completed volunteering work (14, 6.0%) prior to the
outbreak of COVID-19. As a result of the outbreak, 50 (21.41%)
participants stated they were no longer working or had been
furloughed by their employer, whilst 127 (54.3%) had continued
to work, but with appropriate adaptations to match the restrictive
or protective measures implemented by the UK Government.
Women who had continued to work showed a work productivity
loss of 7.9% (measured by the WLQ).
Impact of Employment on General
Emotional Vulnerability and Cognitive
Function
A series of one-way ANOVA’s were performed to examine the
effect of employment status (i.e., continued working, not working
as a result of COVID-19 or not working even prior to the
outbreak) on women’s general anxiety and depression as well
as their cognitive function and COVID-EMV. Results showed
that there was a non-significant effect of employment status
on general anxiety (F < 1, ns), depression [F(2, 231) = 1.4,
ns, ŋ2 partial = 0.01] and cognitive function [F(2, 231) = 1.6,
ns, ŋ2 partial = 0.01]. However, there was a trend towards
significance for COVID-EMV [Working Mean = 14.6, SD = 6.9;
Furloughed or unable work Mean = 13.0, SD = 5.6; Never working
Mean = 15.8, SD = 6.5, F(2, 231) = 2.6, p = 0.08, ŋ2 partial = 0.02].
Post-hoc analyses showed that the achieved statistical power (1-
ß err prob) was greater than 0.95 for all one-way ANOVAs
performed. Moreover, independent t-tests examining the effects
of employment type showed that there were no significant
differences in the level of general anxiety and depression (t < 1,
ns) reported by employed or self-employed women living with
breast cancer (see Table 2 for descriptive statistics).
Impact of COVID-19 Generated Work
Status on Perceptions of Work
There was a significant difference in the view of the importance
of work (t (54.3) = 2.0, p = 0.05, d = 0.4) between women who
“continued” to work (M = 2.8, SD = 1.4) during the COVID-19
outbreak and those who had been furloughed or unable to work
(M = 2.3, SD = 1.5). Women who “continued” to work reported
having a higher view of the importance of work. Similarly, there
was a significant difference [t(54.4) = 3.4, p < 0.01, d = 0.6] found
for the level of job security, with women who “continued” to work
(M = 2.5, SD = 1.4) reporting a greater job security compared
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to those unable to work or furloughed (M = 1.5, SD = 1.6) as a
consequence of the COVID-19 outbreak.
Impact of COVID-19 Induced Job
Security on General Emotional and
Cognitive Function
Depression
The first regression analysis (Table 3) showed that when the
clinical, sociodemographic, and employment type predictors
were entered on step one, they accounted for a modest 5.1% of the
variance in depression. After measures of worry, rumination and
COVID-EMV were added on step two, the model explained an
additional 35.9% [R2(change) = 0.359, F(3, 158) = 32.1, p < 0.001]
of the variance with both rumination (p < 0.001) and COVID-
EMV (p < 0.05) acting as significant predictors. On the third
step, job security significantly predicted depression [t(157) = 2.2,
p = 0.03] after allowing for the effects of the other predictors.
A higher level of job security met with a lower level of depression
in women. Cohen’s f 2 = 0.63 and achieved statistical power (1-ß
err prob) = 0.99.
Anxiety
The results from our second regression analysis (Table 4)
disclosed that the seven demographic variables included in step
one accounted for 6.6% of the variance in anxiety scores reported.
When worry, rumination and COVID-EMV were entered on the
second step, an additional 59.5% of the variance was explained
[R2(change) = 0.595, F(3, 158) = 92.4, p < 0.001] and all
three functioned as significant predictors for levels of anxiety
(p < 0.001). On the final step, women’s job security fell short of
explaining anxiety [t(157) = 1.4, p = 0.18]. Cohen’s f 2 = 1.78 and
achieved statistical power (1-ß err prob) = 0.99.
Emotional Distress
The results from our third regression analysis (Table 5) showed
that when the clinical, sociodemographic and employment type
predictors were entered on step one, they accounted for a modest
6.1% of the variance in emotional distress (as measured by the
HADS-total). After measures of worry, rumination and COVID-
EMV were added on step two, the model explained an additional
57.8% [R2(change) = 0.578, F(3, 158) = 84.5, p < 0.001] of the
variance with rumination, worry and COVID-EMV (p < 0.05)
acting as significant predictors. On the third step, job security
significantly predicted emotional distress [t(157) = 2.2, p = 0.03]
after allowing for the effects of the other predictors. A higher
level of job security met with a lower level of emotional distress
in women. Cohen’s f 2 = 1.66 and achieved statistical power (1-ß
err prob) = 0.99.
Cognitive Function
Our fourth regression analysis (Table 6) revealed that the seven
demographic variables added in step one account for 4.5% of the
variance in cognitive function scores. After worry, rumination
and COVID-EMV were entered on step two, the explained
variance increased by 23.2% [R2(change) = 0.23, F(3, 158) = 16.9,
p < 0.001] with both rumination and COVID-EMV acting as
significant predictors (p. < 0.05). On step three, job security was a
significant predictor of cognitive function [t(157) = 2.2, p = 0.03]
after allowing for the effects of the clinical, sociodemographic and
employment type predictors. Higher job security was associated
with better cognitive function. Cohen’s f 2 = 0.33 and achieved
statistical power (1-ß err prob) = 0.99.
Checks for violation of assumptions showed that the
assumption of collinearity (Tolerance > 0.1, VIF < 10),
independent error (Depression Durbin-Watson = 2.0; Anxiety
Durbin-Watson = 1.9; Emotional Distress Durbin-Watson = 2.0;
Cognitive Function Durbin-Watson = 2.1), normality and
homogeneity of variance and were met for all four regression
analyses performed.
Moderating Role of Cognitive Function in
the Relationship Between Job Security
and Emotional Symptomatology
Our analyses showed that cognitive function significantly
moderated the relationship between job security and anxiety
(b = −0.01, 95% CI [-0.03, -0.00], t = 2.2, p = 0.03). With
higher levels of cognitive function, job security was met with
lower levels of anxiety (b = −0.7, 95% CI [-1.1, -0.2], t = 2.9,
p < 0.01), indicating that the relationship between job security
and anxiety was affected by cognitive function (see Figure 1). In
particular, women with better cognitive functioning and high job
security reported lower levels of anxiety. There was no significant
moderation found for depression.
DISCUSSION
To our knowledge, this is the first study to examine the effects of
COVID-19 induced job insecurity and employment status (i.e.,
working or furloughed) on cognitive function and emotional
health (general anxiety and depression) as well as perceptions of
work and employer support in women living with breast cancer.
As predicted, our results revealed that there were significant
differences in women’s work perceptions depending on their
current work status. Women who had been furloughed, or were
unable to work, as a result of the COVID-19 outbreak, reported
a lower level of work importance compared to those who had
“continued” to work. This suggests that the outbreak of COVID-
19 provoked a re-evaluation of work importance with a more
detrimental effect noted for women who had been left unable
to work. It is plausible that the reduction in work importance
was part of a coping mechanism used by women who had been
furloughed or left unable to work.
Women who were unable to work perceived a greater level of
threat or uncertainty surrounding their long-term job security.
The global economic recession triggered by COVID-19 could
result in 24.7 million job losses worldwide, approximately
two million more than the 2008–2009 global financial crisis
(International Labour Organization, 2020). Given that unplanned
loss of employment is associated with worse mental health
outcomes (Gallo et al., 2000), and that women living with
breast cancer have a pre-existing vulnerability for developing
clinical affective disorders (Burgess et al., 2005; Avis et al.,
2015; Cvetković and Nenadović, 2016; Carreira et al., 2018), this
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TABLE 3 | Hierarchical regression for the predictors of depression.
b SE B β t p
General depression
Step 1
Constant 12.58 (5.32, 19.85) 3.68 3.42 0.00
Education −0.41 (− 1.34, 0.53) 0.47 −0.07 −0.86 0.39
Grade 0.45 (− 0.47, 1.37) 0.47 0.08 0.96 0.34
Active treatment status −0.68 (− 2.78, 1.42) 1.06 −0.05 −0.64 0.52
Age at diagnosis −0.06 (− 0.15, 0.03) 0.05 −0.10 −1.23 0.22
Time since diagnosis (months) −0.02 (− 0.04, 0.01) 0.01 −0.13 −1.51 0.13
Charlson co-morbidity index −0.11 (− 0.92, 0.70) 0.41 −0.02 −0.27 0.79
Employment type −0.62 (− 1.73, 0.49) 0.56 −0.09 −1.10 0.27
Step 2
Constant 1.59 (− 4.78, 7.96) 3.22 0.49 0.62
Education −0.04 (− 0.80, 0.71) 0.38 −0.01 −0.11 0.91
Grade 0.15 (− 0.59, 0.89) 0.38 0.03 0.4 0.69
Active treatment status −1.32 (− 3.02, 0.39) 0.87 −0.10 −1.52 0.13
Age at diagnosis −0.02 (− 0.09, 0.05) 0.04 −0.04 −0.53 0.60
Time since diagnosis (months) 0.01 (− 0.01, 0.02) 0.01 0.04 0.63 0.53
Charlson co-morbidity index 0.21 (− 0.44, 0.86) 0.33 0.04 0.63 0.53
Employment type −0.36 (− 1.25, 0.53) 0.45 −0.05 −0.8 0.43
Pathological worry 0.02 (− 0.03, 0.06) 0.02 0.06 0.69 0.49
Rumination (RRS) 0.12 (0.08, 0.17) 0.02 0.44 5.39 0.00
COVID-EMV 0.13 (0.03, 0.24) 0.05 0.22 2.50 0.01
Step 3
Constant 2.54 (− 3.81, 8.89) 3.21 0.79 0.43
Education −0.01 (− 0.76, 0.74) 0.38 0.00 −0.03 0.98
Grade 0.20 (− 0.53, 0.93) 0.37 0.03 0.54 0.59
Active treatment status −1.30 (− 2.99, 0.39) 0.86 −0.10 −1.52 0.13
Age at diagnosis −0.02 (− 0.09, 0.05) 0.04 −0.04 −0.57 0.57
Time since diagnosis (months) 0.01 (− 0.01, 0.02) 0.01 0.06 0.83 0.41
Charlson co-morbidity index 0.19 (− 0.46, 0.83) 0.33 0.04 0.57 0.57
Employment type −0.45 (− 1.33, 0.43) 0.45 −0.07 −1.00 0.32
Pathological worry 0.01 (− 0.03, 0.06) 0.02 0.05 0.60 0.55
Rumination (RRS) 0.12 (0.08, 0.16) 0.02 0.43 5.37 0.00
COVID-EMV 0.13 (0.02, 0.23) 0.05 0.21 2.40 0.02
Job security −0.36 (− 0.67, −0.04) 0.16 −0.14 −2.20 0.03
95% confidence intervals.
finding has important implications. In particular, we advocate
that women furloughed by employers or who are unable to
work as a result of the pandemic would likely benefit from
the early implementation of interventions and support services
that improve emotional and psychological resilience. Emotional
distress in breast cancer survivors has been associated with poorer
quality of life (Zeng et al., 2016), lower cognitive function (Von
Ah and Tallman, 2015) and a high level of fatigue (Vardy et al.,
2019), as well as reduced adherence to crucial treatment and
medications, increasing the risk of mortality (see Theofilou and
Panagiotaki, 2012 for a review). Studies show that higher levels
of depression, fatigue and poorer cognitive function are in turn
linked to worse work productivity and output (Calvio et al., 2010;
Zeng et al., 2016; Von Ah et al., 2018). It is important that
women who have been left unable to work or furloughed as a
result of the COVID-19 outbreak have a high emotional resilience
on their return to work as this will likely improve their work
efficiency, and potentially reduce the risk of them being selected
for redundancy against other candidates.
Compounding this, findings further showed that job
insecurity was a significant predictor for greater levels of
depression and poorer cognitive function across the entire
sample. Previous research has shown that threat to job security
is significantly associated with increased depressive symptoms
including, loss of interest, lack of energy and lower mood
(Blom et al., 2015). Similarly, we found rumination and
COVID-EMV to be significant predictors of depression and
cognitive function (Nolen-Hoeksema, 2000; Beckwé et al., 2014;
Spinhoven et al., 2018). Such findings suggest that experiencing
job insecurity exacerbates pre-existing cognitive and emotional
vulnerabilities (depression) commonly reported by women
diagnosed with breast cancer.
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TABLE 4 | Hierarchical regression for the predictors of anxiety.
b SE B β t p
Anxiety
Step 1
Constant 16.31 (8.08, 24.54) 4.17 3.91 0.00
Education −1.09 (− 2.15, −0.03) 0.54 −0.16 −2.03 0.04
Grade −0.15 (− 1.19, 0.90) 0.53 −0.02 −0.28 0.78
Active treatment status 1.40 (− 0.98, 3.78) 1.21 0.09 1.16 0.25
Age at diagnosis −0.08 (− 0.19, 0.02) 0.05 −0.13 −1.56 0.12
Time since diagnosis (months) −0.02 (− 0.04, 0.00) 0.01 −0.13 −1.63 0.11
Charlson co-morbidity index −0.36 (− 1.28, 0.56) 0.47 −0.06 −0.78 0.44
Employment type −0.33 (− 1.58, 0.56) 0.64 −0.04 −0.51 0.61
Step 2
Constant −2.40 (− 7.91, 3.12) 2.79 −0.86 0.39
Education −0.38 (− 1.03, 0.27) 0.33 −0.06 −1.15 0.25
Grade −0.40 (− 1.04, 0.25) 0.33 −0.06 −1.22 0.23
Active treatment status 1.03 (− 0.45, 2.51) 0.75 0.07 1.38 0.17
Age at diagnosis −0.02 (− 0.09, 0.04) 0.03 −0.03 −0.67 0.51
Time since diagnosis (months) 0.01 (− 0.01, 0.02) 0.01 0.06 1.08 0.28
Charlson co-morbidity index 0.21 (− 0.36, 0.77) 0.29 0.04 0.73 0.47
Employment type 0.16 (− 0.61, 0.93) 0.39 0.02 0.41 0.69
Pathological worry 0.09 (0.05, 0.13) 0.02 0.30 4.61 0.00
Rumination (RRS) 0.09 (0.05, 0.13) 0.02 0.28 4.52 0.00
COVID-EMV 0.26 (0.17, 0.35) 0.05 0.38 5.66 0.00
Step 3
Constant −1.89 (− 7.44, 3.66) 2.81 −0.67 0.50
Education −0.36 (− 1.01, 0.29) 0.33 −0.05 −1.10 0.28
Grade −0.37 (− 1.01, 0.27) 0.32 −0.05 −1.13 0.26
Active treatment status 1.04 (− 0.43, 2.52) 0.75 0.07 1.40 0.17
Age at diagnosis −0.02 (− 0.09, 0.04) 0.03 −0.04 −0.69 0.49
Time since diagnosis (months) 0.01 (− 0.01, 0.02) 0.01 0.06 1.20 0.23
Charlson co-morbidity index 0.20 (− 0.37, 0.76) 0.29 0.03 0.68 0.50
Employment type 0.11 (− 0.66, 0.88) 0.39 0.01 0.28 0.78
Pathological worry 0.09 (0.05, 0.12) 0.02 0.29 4.56 0.00
Rumination (RRS) 0.09 (0.05, 0.13) 0.02 0.28 4.48 0.00
COVID-EMV 0.26 (0.17, 0.35) 0.05 0.38 5.59 0.00
Job security −0.19 (− 0.47, 0.09) 0.14 −0.06 −1.35 0.18
95% confidence intervals.
Although it has been reported previously that threat to job
security in nurses is associated with increased depression and
anxiety (Boya et al., 2008), our study found no association with
anxiety. However, in line with previous studies, our findings
showed that both worry and rumination were significantly
associated with anxiety (Nolen-Hoeksema, 2000; Ryum et al.,
2017; Brown et al., 2020). Similarly, women’s COVID-EMV was
a significant predictor. One possible explanation for our non-
significant finding is that the anxiety experienced by women
living with breast cancer during the peak of the COVID-
19 pandemic, when our study was conducted, was associated
more with persistent negative thinking and fear of the possible
implications if they were to catch this novel virus (e.g., high risk of
health complications and premature mortality), as opposed to job
insecurity. It is important that we continue to assess the effects of
threat to job security and possible COVID-19 related job loss on
anxiety after the peak of the COVID-19 outbreak and the lifting
of restrictive measures. This will provide us with a greater insight
into the specific factors triggering the symptoms of anxiety in
women living with breast cancer.
Of focal importance, we identified that cognitive function
moderated the relationship between job security and anxiety.
That is, women with better cognitive function were less
vulnerable to anxiety when job security was less of a concern.
Previous studies indicate that cognitive function has a protective
effect in attenuating emotional vulnerability (anxiety and
depression) in women living with breast cancer. A large cross-
sectional study showed that self-reported cognitive function was
significantly associated with emotional vulnerability such that
a better cognitive function was coupled with greater emotional
well-being (Chapman et al., 2019). In addition, an intervention
study conducted by Swainston and Derakshan (2018) revealed
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TABLE 5 | Hierarchical regression for the predictors of emotional distress (as measured by the HADS-total).
b SE B β t p
Emotional distress
Step 1
Constant 29.13 (15.18, 43.07) 7.06 4.13 0.00
Education −1.47 (− 3.27, 0.32) 0.91 −0.13 −1.62 0.11
Grade 0.18 (− 1.59, 1.95) 0.90 0.02 0.20 0.84
Active treatment status 0.76 (− 3.27, 4.79) 2.04 0.03 0.37 0.71
Age at diagnosis −0.14 (− 0.31, 0.04) 0.09 −0.13 −1.55 0.12
Time since diagnosis (months) −0.04 (− 0.08, 0.00) 0.02 −0.15 −1.81 0.07
Charlson co-morbidity index −0.50 (− 2.06, 1.06) 0.79 −0.05 −0.64 0.52
Employment type −0.99 (− 3.12, 1.13) 1.08 −0.07 −0.92 0.36
Step 2
Constant −0.61 (− 10.21, 8.99) 4.86 −0.13 0.90
Education −0.39 (− 1.53, 0.75) 0.58 −0.03 −0.67 0.50
Grade −0.37 (− 1.49, 0.75) 0.57 −0.03 −0.65 0.52
Active treatment status −0.22 (− 2.80, 2.35) 1.31 −0.01 −0.17 0.86
Age at diagnosis −0.04 (− 0.15, 0.07) 0.06 −0.04 −0.71 0.48
Time since diagnosis (months) 0.01 (− 0.01, 0.04) 0.01 0.05 1.00 0.32
Charlson co-morbidity index 3.96 (− 0.59, 1.38) 0.50 0.04 0.79 0.43
Employment type −0.26 (− 1.60, 1.08) 0.68 −0.02 −0.39 0.70
Pathological worry 0.10 (0.03, 0.16) 0.03 0.19 2.94 0.00
Rumination (RRS) 0.21 (0.14, 0.28) 0.03 0.39 6.19 0.00
COVID-EMV 0.41 (0.25, 0.57) 0.08 0.35 5.08 0.00
Step 3
Constant 0.84 (− 8.73, 10.41) 4.85 0.17 0.86
Education −0.34 (− 1.47, 0.78) 0.57 −0.03 −0.60 0.55
Grade −0.29 (− 1.40, 0.81) 0.56 −0.03 −0.52 0.60
Active treatment status −0.20 (− 2.75, 2.35) 1.29 −0.01 −0.16 0.88
Age at diagnosis −0.04 (− 0.15, 0.07) 0.06 −0.04 −0.76 0.45
Time since diagnosis (months) 0.02 (− 0.01, 0.04) 0.01 0.06 1.20 0.23
Charlson co-morbidity index 0.36 (− 0.61, 1.33) 0.49 0.04 0.73 0.47
Employment type −0.39 (− 1.73, 0.93) 0.67 −0.03 −0.59 0.56
Pathological worry 0.09 (0.03, 0.16) 0.03 0.19 2.88 0.01
Rumination (RRS) 0.21 (0.14, 0.27) 0.03 0.39 6.19 0.00
COVID-EMV 0.40 (0.24, 0.56) 0.08 0.34 5.01 0.00
Job security −0.54 (− 1.03, −0.06) 0.24 −0.11 −2.24 0.03
95% confidence intervals.
that women who received adaptive cognitive training (i.e., dual
n-back training) reported less anxiety symptomology compared
to the active control group. The moderating effect of cognitive
function found in this study further corroborates the notion that
in women living with a diagnosis of breast cancer, cognitive
ability protects against the development of severe emotional
symptomologies including, anxiety. Our findings suggest that
women with lower cognitive function may benefit more from
adaptive cognitive training interventions that improve cognitive
efficiency particularly when there is a threat to their job security.
Collectively, our results suggest that the impact of the
COVID-19 outbreak on work and employment (e.g., increased
job insecurity) risks women living with breast cancer being
susceptible to developing affective disorders and poorer cognitive
function. Based on our findings we recommend that both
employers and the UK Government consider providing more
accessible support to ameliorate emotional and cognitive health.
In particular, we suggest the remote implementation of therapies
such as positive psychotherapy (Ochoa et al., 2017) and CBT
(Eichler et al., 2015; Ren et al., 2019) as well as adaptive
cognitive training (Swainston and Derakshan, 2018) to reduce
both anxiety and depression and promote cognitive efficiency.
We also advocate that where possible; employers offer women
the opportunity to vocalize their concerns about possible job
insecurity. Such open discussions may alleviate distress and
depression or alternatively allow better preparation in the
eventually of job loss.
Limitations
The current study presents some limitations that need to be
considered when interpreting the results. Firstly, our study was
cross-sectional and therefore provides only a snapshot of the
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experiences of the women at the time of the questionnaire
and also limits explanations around cause and effect. Previous
research conducted by Chapman et al. (2019) found evidence
for a bi-directional relationship between self-reported cognitive
function and emotional well-being in women living with a
diagnosis of breast cancer. We advocate that future research
conduct longitudinal studies with multiple follow-up sessions
as this will provide us with vital information on the trends
of how COVID-19 impacts cognitive and emotional health
across the pandemic. By assessing the trends and the specific
predictors associated with anxiety and depression symptoms, as
well as poorer cognitive function, we could provide more targeted
support and interventions and thus reduce the risk of clinical
affective disorders.
A second limitation is participants were asked to self-
report their demographic information including, breast cancer
history and pre-existing psychological or affective disorders.
In the future, we would recommend that medical records
are obtained and assessed to ensure the reliability of the
information reported. Finally, we recruited all of our participants
using voluntary sampling via online advisements placed
on social media platforms (i.e., Twitter) due to the social
restrictions and shielding imposed by the UK Government
during the peak of the COVID-19 outbreak. As a consequence,
our sample of women may not be representative of the
much wider breast cancer population. The sample was also
well-educated and primarily Caucasian (95%) indicating
that women living with a breast cancer diagnosis from
BAME backgrounds are underrepresented in our study. We
suggest that future research recruit women from multiple
sources including, referral from oncologists or other health
care professionals.
TABLE 6 | Hierarchical regression for the predictors of cognitive function.
b SE B β t p
Cognitive function
Step 1
Constant 83.56 (31.79, 135.33) 26.22 3.19 0.00
Education 2.88 (− 3.79, 9.55) 3.38 0.07 0.85 0.40
Grade −4.63 (− 11.19, 1.94) 3.32 −0.11 −1.39 0.17
Active treatment status −9.93 (− 24.91, 5.04) 7.58 −0.11 −1.31 0.19
Age at diagnosis 0.50 (− 0.16, 1.15) 0.33 0.13 1.50 0.14
Time since diagnosis (months) 0.10 (− 0.05, 0.25) 0.07 0.11 1.36 0.18
Charlson co-morbidity index −1.67 (− 7.45, 4.12) 2.93 −0.05 −0.57 0.57
Employment type −0.93 (− 8.82, 6.95) 3.99 −0.02 −0.23 0.82
Step 2
Constant 140.11 (90.03, 190.19) 25.35 5.53 0.00
Education 0.94 (− 5.00, 6.88) 3.01 0.02 0.31 0.76
Grade −2.85 (− 8.67, 2.98) 2.95 −0.07 −0.97 0.34
Active treatment status −6.54 (− 19.98, 6.90) 6.81 −0.07 −0.96 0.34
Age at diagnosis 0.30 (− 0.27, 0.88) 0.29 0.08 1.04 0.30
Time since diagnosis (months) −0.03 (− 0.17, 0.10) 0.07 −0.03 −0.44 0.66
Charlson co-morbidity index −3.49 (− 8.63, 1.65) 2.60 −0.10 −1.34 0.18
Employment type −1.88 (− 8.87, 5.12) 3.54 −0.04 −0.53 0.60
Pathological worry 0.12 (− 0.22, 0.46) 0.17 0.07 0.71 0.48
Rumination (RRS) −0.74 (− 1.09, −0.40) 0.18 −0.38 −4.21 0.00
COVID-EMV −1.01 (− 1.84, −0.18) 0.42 −0.24 −2.40 0.02
Step 3
Constant 132.81 (82.85, 182.77) 25.29 5.25 0.00
Education 0.69 (− 5.18, 6.57) 2.97 0.02 0.23 0.82
Grade −3.24 (− 9.00, 2.53) 2.92 −0.08 −1.11 0.27
Active treatment status −6.65 (− 19.94, 6.64) 6.73 −0.07 −0.99 0.32
Age at diagnosis 0.31 (− 0.26, 0.88) 0.29 0.08 1.08 0.28
Time since diagnosis (months) −0.04 (− 0.18, 0.09) 0.07 −0.05 −0.63 0.53
Charlson co-morbidity index −3.31 (− 8.40, 1.77) 2.57 −0.09 −1.29 0.20
Employment type −1.19 (− 8.13, 5.75) 3.52 −0.02 −0.34 0.74
Pathological worry 0.14 (− 0.20, 0.48) 0.17 0.08 0.81 0.42
Rumination (RRS) −0.73 (− 1.08, −0.39) 0.18 −0.37 −4.18 0.00
COVID-EMV −0.96 (− 1.78, −0.13) 0.42 −0.22 −2.30 0.02
Job security 2.74 (0.23, 5.25) 1.27 0.15 2.16 0.03
95% confidence intervals.
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FIGURE 1 | Simple slope equations for the regression of anxiety on job security at three levels of cognitive function.
CONCLUSION
To conclude, the current study showed that women living with
breast cancer who were furloughed or unable to work as a result of
the COVID-19 pandemic reported a greater level of job insecurity
compared to those who had “continued” with their normal work
duties. Furthermore, this is the first study to show that women
working with a diagnosis of breast cancer are at an increased
risk for experiencing affective disorders (anxiety and depression)
and poorer cognitive function as a consequence of job insecurity
created by the COVID-19 outbreak and associated restrictive
measures. We suggest the implementation of accessible adaptive
cognitive training interventions and supportive therapies such as
CBT to ameliorate the cognitive and emotional health of women
experiencing concerns about their future job security.
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